Literature DB >> 15560966

Schizophrenia patients demonstrate a distinctive pattern of decision-making impairment on the Iowa Gambling Task.

Brett Shurman1, William P Horan, Keith H Nuechterlein.   

Abstract

Although dorsolateral prefrontal cortex (DLPFC) abnormalities in schizophrenia are well established, several lines of evidence suggest the orbitofrontal cortex (OFC) may also be dysfunctional in this disorder. We examined the performance of schizophrenia patients and nonpatient controls on the Iowa Gambling Task [Cognition 50 (1994) 7], a decision-making task sensitive to OFC damage that involves a series of selections from four decks of cards that vary in their reward/punishment profiles. Patients also completed neuropsychological tests assessing DLPFC functions and clinical symptom assessments. The schizophrenic patients demonstrated a pattern of impaired performance that differed both from healthy controls and from the "non-conservative" pattern typically found in patients with OFC lesions. The patients selected from the two card decks that had low frequency and high magnitude punishments significantly more often than the decks with high frequency and low magnitude punishments. Performance on the task was not strongly related to tests sensitive to DLPFC dysfunction but was correlated with negative symptoms. Results suggest that individuals with schizophrenia display a pattern of compromised decision-making that is somewhat distinct from that found in OFC lesion patients and that may be linked to certain clinical symptoms.

Entities:  

Mesh:

Year:  2005        PMID: 15560966     DOI: 10.1016/j.schres.2004.03.020

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  70 in total

1.  Prefrontal D2-receptor stimulation mediates flexible adaptation of economic preference hierarchies.

Authors:  Thilo van Eimeren; Ji H Ko; Giovanna Pellechia; Sang S Cho; Sylvain Houle; Antonio P Strafella
Journal:  Hum Brain Mapp       Date:  2011-10-22       Impact factor: 5.038

Review 2.  Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions.

Authors:  Deanna M Barch; Erin C Dowd
Journal:  Schizophr Bull       Date:  2010-06-21       Impact factor: 9.306

Review 3.  Motivational Deficits in Schizophrenia and the Representation of Expected Value.

Authors:  James A Waltz; James M Gold
Journal:  Curr Top Behav Neurosci       Date:  2016

4.  Effects of Acute Stress on Decision Making.

Authors:  Stephanie E Wemm; Edelgard Wulfert
Journal:  Appl Psychophysiol Biofeedback       Date:  2017-03

Review 5.  Neuropsychiatric effects of cocaine use disorders.

Authors:  Charles U Nnadi; Olubansile A Mimiko; Henry L McCurtis; Jean Lud Cadet
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

6.  Inactivation of the prelimbic or infralimbic cortex impairs decision-making in the rat gambling task.

Authors:  Fiona D Zeeb; P J J Baarendse; L J M J Vanderschuren; Catharine A Winstanley
Journal:  Psychopharmacology (Berl)       Date:  2015-09-21       Impact factor: 4.530

7.  Eyeblink conditioning in unmedicated schizophrenia patients: a positron emission tomography study.

Authors:  Krystal L Parker; Nancy C Andreasen; Dawei Liu; John H Freeman; Daniel S O'Leary
Journal:  Psychiatry Res       Date:  2013-10-01       Impact factor: 3.222

8.  Dysfunction of a cortical midline network during emotional appraisals in schizophrenia.

Authors:  Daphne J Holt; Balaji Lakshmanan; Oliver Freudenreich; Donald C Goff; Scott L Rauch; Gina R Kuperberg
Journal:  Schizophr Bull       Date:  2009-07-15       Impact factor: 9.306

9.  The Outcome-Representation Learning Model: A Novel Reinforcement Learning Model of the Iowa Gambling Task.

Authors:  Nathaniel Haines; Jasmin Vassileva; Woo-Young Ahn
Journal:  Cogn Sci       Date:  2018-10-05

Review 10.  The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs.

Authors:  Ann M Kring; Deanna M Barch
Journal:  Eur Neuropsychopharmacol       Date:  2014-01-22       Impact factor: 4.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.